Today's society is confronted with ever increasing health care costs. One of the factors is the cost of drug innovations. Diseases waiting for therapeutic solutions, are complicated and multifactorial in nature. As a result, drug innovation has become even more complex leading to high tech and therefore high cost solutions.
The question arises, what is the added value of such high cost innovations and how can it be determined when both benefit and harm are considered. Health economics, and more specific pharmacoeconomics aims to provide a neutral scientific approach to this challenge.
Period
11-07-2011 - 15-07-2011 (1 weeks)
Target group
Postgraduates, clinicians and professionals within governments, industry, universities with a basic knowledge of epidemiology and an interest in pharmacoeconomics and benefit/risk evaluation of medicines.
Course aim
This course aims to provide a broad perspective of the field, including a variety of subjects from views of the different stakeholders to more in depth methodological approaches, illustrated with examples and exercises.
Credits
0.0 ECTS credits+ Certificate of Attendance
Course fee
EUR 1100 Course + course materials + housing
Course leader
Dr. A.H. Maitland-van der Zee and Dr. A. Hovels
Scholarships
Utrecht Summer School doesn't offer scholarships for this course.
Utrecht University
Address: PO BOX 80148
Postal code: 3508 TC
City: Utrecht
Country: Netherlands
Website: http://www.utrechtsummerschool.nl
E-mail: summerschool@uu.nl
Phone: 0031302534400
Pharmacoeconomics
